Document Detail

Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells.
MedLine Citation:
PMID:  19377286     Owner:  NLM     Status:  MEDLINE    
Prostate cancer (PCa), next only to skin cancer, is the most commonly occurring malignancy in men in the US. Aging is recognized as a major risk factor for this neoplasm as a man's chance for developing this disease significantly increases with increasing age. Because aging is inevitable, Americans are living longer, and the existing treatments have not been able to manage this neoplasm, novel mechanism-based approaches are needed. We have recently shown that Sirt1, a sirtuin class III histone deacetylases (HDACs) originally linked to aging and longevity in yeast, was overexpressed in human PCa cells and PCa tissues obtained from patients. We also found that chemical inhibition and/or genetic knockdown of Sirt1 caused a FoxO1-mediated inhibition in the growth and viability of human PCa cells. Since p53 is a target for deacetylation by Sirt1, we wanted to determine the involvement of p53 in Sirt1 inhibition mediated responses in PCa. To achieve our objective, we utilized a pair of isogenic PCa cell lines viz. PC3 and PC3-p53, which differ only in p53 status. Our data demonstrated that Sirt1 inhibition caused a decrease in cell growth, cell viability and the colony formation ability of both cell lines. Further, Sirt1 inhibition resulted in an increase in FoxO1 acetylation and subsequent transcriptional activation in both cell types regardless of p53 status. However, an interesting observation of our study was that Sirt1 inhibition resulted in an increase in senescence in PC3-p53 cells whereas it resulted in an increase in apoptosis in PC3 cells. The results of this study compliment our previous study and suggest that Sirt1 inhibition may have different downstream targets in cells with active p53 versus cells where p53 is inactive.
Brittney Jung-Hynes; Nihal Ahmad
Related Documents :
9855116 - Apoptotic cell death of high polyploid cells in a cultured sarcoma cell line.
19109096 - Upon oxidative stress, the antiapoptotic hsp60/procaspase-3 complex persists in mucoepi...
15107826 - Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and depe...
21444956 - Cell death induced by the application of alternating magnetic fields to nanoparticle-lo...
8098726 - Correlation of oncostatin m secretion by human retrovirus-infected cells with potent gr...
25285626 - Collagen-derived dipeptide prolyl-hydroxyproline promotes differentiation of mc3t3-e1 o...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-05-13
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  8     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-14     Completed Date:  2009-10-13     Revised Date:  2010-09-27    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1478-83     Citation Subset:  IM    
Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Proliferation
Prostatic Neoplasms / genetics,  metabolism*,  pathology*
Sirtuin 1
Sirtuins / genetics,  metabolism*
Tumor Suppressor Protein p53 / genetics,  metabolism*
Grant Support
Reg. No./Substance:
0/Tumor Suppressor Protein p53; EC 3.5.1.-/SIRT1 protein, human; EC 3.5.1.-/Sirtuin 1; EC 3.5.1.-/Sirtuins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epigenetic inheritance through self-recruitment of the polycomb repressive complex 2.
Next Document:  Effects of N-cadherin overexpression on the adhesion properties of embryonic stem cells.